Browse > Article
http://dx.doi.org/10.5352/JLS.2009.19.7.871

G1 Arrest of U937 Human Monocytic Leukemia Cells by Sodium Butyrate, an HDAC Inhibitor, Via Induction of Cdk Inhibitors and Down-regulation of pRB Phosphorylation  

Choi, Yung-Hyun (Department of Biochemistry, Dongeui University College of Oriental Medicine and Department of Biomaterial Control, Dongeui University)
Publication Information
Journal of Life Science / v.19, no.7, 2009 , pp. 871-877 More about this Journal
Abstract
We investigated the effects of sodium butyrate, a histone deacetylase inhibitor, on the cell cycle progression in human monocytic leukemia U937 cells. Exposure of U937 cells to sodium butyrate resulted in growth inhibition, G1 arrest of the cell cycle and induction of apoptosis in a dose-dependent manner as measured by MTT assay and flow cytometry analysis. The increase in G1 arrest was associated with the down-regulation in cyclin D1, E, A, cyclin-dependent kinase (Cdk) 4 and 6 expression, and up-regulation of Cdk inhibitors such as p21 and p27. Sodium butyrate treatment also inhibited the phosphorylation of retinoblastoma protein (pRB) and p130, however, the levels of transcription factors E2F-1 and E2F-4 were not markedly modulated. Furthermore, the down-regulation of phosphorylation of pRB and p130 by this compound was associated with enhanced binding of pRB and E2F-1, as well as p130 and E2F-4, respectively. Overall, the present results demonstrate a combined mechanism involving the inhibition of pRBjp130 phosphorylation and induction of Cdk inhibitors as targets for sodium butyrate that may explain some of its anti-cancer effects in U937 cells.
Keywords
Sodium butyrate; G1 arrest; Cdk inhibitors; pRB/p130;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81, 323-330   DOI   ScienceOn
2 Yen, A. and R. Sturgill. 1998. Hypophosphorylation of the RB protein in S and G2 as well as G1 during growth arrest. Exp. Cell Res. 241, 324-331   DOI   ScienceOn
3 Johansson, M. and J. L. Persson. 2008. Cancer therapy: targeting cell cycle regulators. Anticancer Agents Med. Chem. 8, 723-731   DOI   ScienceOn
4 Kruh, J. 1982. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell Biochem. 42, 65-82
5 Li, X., M. Marani, R. Mannucci, B. Kinsey, F. Andriani, I. Nicoletti, L. Denner, and M. Marcelli. 2001. Overexpression of BCL-X (L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res. 61, 1699-1706
6 Litvak, D. A., K. O. Hwang, B. M. Evers, and C. M. Townsend. 2000. Induction of apoptosis in human gastric cancer by sodium butyrate. Anticancer Res. 20, 779-784
7 Loo, D. T. and J. R. Rillema. 1998. Measurement of cell death. Methods Cell Biol. 57, 251-264   DOI
8 Madigan, M. C., G. Chaudhri, P. L. Penfold, and R. M. Conway. 1999. Sodium butyrate modulates p53 and Bcl-2 expression in human retinoblastoma cell lines. Oncol. Rep. 7, 331-337
9 Morgan, D. 1997. Cyclin dependent kinases: Engines, clocks and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291   DOI   ScienceOn
10 Sandal, T. 2002. Molecular aspects of the mammalian cell cycle and cancer. Oncologist 7, 73-81   DOI   ScienceOn
11 Schwartz, B., C. Avivi-Green, and S. Polak-Charcon. 1998. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol. Cell Biochem. 188, 21-30   DOI   ScienceOn
12 Schwartz, G. K. and M. A. Shah. 2005. Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23, 9408-9421   DOI   ScienceOn
13 Sherr, C. J. and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163   DOI   ScienceOn
14 Baradari, V., A. Huether, M. Höpfner, D. Schuppan, and H. Scherübl. 2006. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Endocr. Relat. Cancer 13, 1237-1250   DOI   ScienceOn
15 Candido, E. P., R. Reeves, and J. R. Davie. 1978. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14, 105-113   DOI   ScienceOn
16 Chopin, V., R. A. Toillon, N. Jouy, and X. Le Bourhis. 2004. P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 23, 21-29   DOI   ScienceOn
17 Cummings, J. H. 1981. Short chain fatty acids in the human colon. Gut 22, 763-779   DOI   ScienceOn
18 Danova, M., M. Giordano, and G. A. Mazzini. 1990. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leuk. Res. 14, 417-422   DOI   ScienceOn
19 Greenberg, V. L., J. M. Williams, J. P. Cogswell, M. Mendenhall, and S. G. Zimmer. 2001. Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. Thyroid 11, 315-325   DOI   ScienceOn
20 Elledges, S. J. and J. W. Harper. 1994. Cdk inhibitor: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6, 847-852   DOI   ScienceOn
21 Hara, I., H. Miyake, S. Hara, S. Arakawa, and S. Kamidono. 2000. Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas-mediated cytotoxicity. Int. J. Oncol. 17, 1213-1218
22 Ibraghimov-Beskrovnaya, O. 2007. Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy. Cell Cycle 6, 776-779   DOI   ScienceOn
23 Wang, Y. F., N. S. Chen, Y. P. Chung, L. H. Chang, Y. H. Chiou, and C. Y. Chen. 2006. Sodium butyrate induces apoptosis and cell cycle arrest in primary effusion lymphoma cells independently of oxidative stress and p21(CIP1/WAF1) induction. Mol. Cell Biochem. 14, 1-9
24 Archer, S. Y., J. Johnson, H. J. Kim, Q. Ma, H. Mou, V. Daesety, S. Meng, and R. A. Hodin. 2005. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G696-703
25 Sidle, A., C. Palaty, P. Dirks, O. Wiggan, M. Kiess, R. M. Gill, A. K. Wong, and P. A. Hamel. 1996. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit. Rev. Biochem. Mol. Biol. 31, 237-271   DOI   ScienceOn
26 Tsai, L. C., M. W. Hung, G. G. Chang, and T. C. Chang, 2000. Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells. Anticancer Res. 20, 2441-2448
27 Vaziri, C., L. Stice, and D. V. Faller. 1998. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ. 9, 465-474
28 Wang, A., R. Zeng, and H. Huang. 2008. Retinoic acid and sodium butyrate as cell cycle regulators in the treatment of oral squamous carcinoma cells. Oncol. Res. 17, 175-182   DOI   ScienceOn